GLP-1/GIP analogue

glucose-dependent peptide analogue combining GLP-1 and GIP activity

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLP-1/GIP analogue, covering 2024-01-12 to 2024-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue [Phase 1, Phase 2]

See pricing